IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Inventiva S.A.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026
$2.98+0.04 (+1.36%)
Close on Oct 19, 2026
Share price
−$1.87 (−38.56%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Inventiva S.A. saw revenue fall 51.3% to €4.48M over fiscal 2025.
Revenue
€4.48M
-51.3% vs. a year earlier
Operating income
-€141.01M
FY2025
EPS, diluted
-1.90 EUR
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- €4.48M
- EPS, diluted
- -1.90 EUR
Valuation needs the share price. It fills in once daily prices are connected and converted from EUR.
Nine years at a glance
Fiscal years 2017 to 2025, EUR
Revenue
€4.48M-51.3% YoY
Operating income
-€141.01M
EPS, diluted
-1.90 EUR
Reported period